Published on in Vol 6 , No 3 (2020) :Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19538, first published .
Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

Authors of this article:

Guosheng Yin 1 Author Orcid Image ;   Chenyang Zhang 1 Author Orcid Image ;   Huaqing Jin 1 Author Orcid Image
There are currently no tweets available for this article within the specified range.